Switching Therapies in Multiple Sclerosis

被引:0
|
作者
Patricia K. Coyle
机构
[1] Stony Brook University Medical Center,Department of Neurology
来源
CNS Drugs | 2013年 / 27卷
关键词
Multiple Sclerosis; Multiple Sclerosis Patient; Progressive Multifocal Leukoencephalopathy; Natalizumab; Glatiramer Acetate;
D O I
暂无
中图分类号
学科分类号
摘要
There are currently nine approved disease modifying therapies for relapsing forms of multiple sclerosis, with six distinct mechanisms of action. All have side effects, and none are cures. When a patient cannot tolerate therapy, or there is unacceptable breakthrough disease activity, the most common approach is to change drug. No universal guidelines exist for switching therapy. This overview will propose switch principles and suggestions.
引用
收藏
页码:239 / 247
页数:8
相关论文
共 50 条
  • [21] Oral Therapies for Multiple Sclerosis
    Faissner, Simon
    Gold, Ralf
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2019, 9 (01):
  • [22] Combination therapies in multiple sclerosis
    Gold, Ralf
    JOURNAL OF NEUROLOGY, 2008, 255 (Suppl 1) : 51 - 60
  • [23] New therapies for multiple sclerosis
    Khan, OA
    Jiang, H
    CHEMISTRY & INDUSTRY, 1996, (05) : 166 - 169
  • [24] Integrative therapies for multiple sclerosis
    Maker-Clark, Geeta
    Patel, Smita
    DM DISEASE-A-MONTH, 2013, 59 (08): : 290 - 301
  • [25] New therapies for multiple sclerosis
    Besson, G
    Carpentier, F
    PRESSE MEDICALE, 1998, 27 (39): : 2032 - 2035
  • [26] Multiple sclerosis: Symptomatic therapies
    Metz, L
    SEMINARS IN NEUROLOGY, 1998, 18 (03) : 389 - 395
  • [27] Multiple Sclerosis Therapies in Pediatric Patients With Refractory Multiple Sclerosis
    Yeh, E. Ann
    Waubant, Emmanuelle
    Krupp, Lauren B.
    Ness, Jayne
    Chitnis, Tanuja
    Kuntz, Nancy
    Ramanathan, Murali
    Belman, Anita
    Chabas, Dorothee
    Gorman, Mark P.
    Rodriguez, Moses
    Rinker, John Robert, II
    Weinstock-Guttman, Bianca
    ARCHIVES OF NEUROLOGY, 2011, 68 (04) : 437 - 444
  • [28] The Multiple Roles of B Cells in Multiple Sclerosis and Their Implications in Multiple Sclerosis Therapies
    Li, Rui
    Bar-Or, Amit
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2019, 9 (04):
  • [29] Switching disease-modifying therapies in multiple sclerosis: follow-up of 108 patients
    Morra, VB
    Lanzillo, R
    Pagano, A
    Vacca, G
    Longobardi, R
    Schiavone, V
    Ascione, S
    De Michele, G
    Orefice, G
    MULTIPLE SCLEROSIS, 2005, 11 : S159 - S159
  • [30] Changes in cognitive functions after disease-modifying therapies switching in persons with multiple sclerosis
    Ozakbas, Serkan
    Yigit, Pinar
    Sagici, Ozge
    Ozdogar, Asiye Tuba
    Abasiyanik, Zuhal
    Kahraman, Turhan
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (07) : 1050 - 1050